Stem cells are the body’s raw materials, cells that can both copy themselves and transform into specialized cell types like muscle, blood, or nerve cells. These two abilities, self-renewal and differentiation, set them apart from every other cell in your body. A skin cell can only make more skin cells, but a stem cell can divide while maintaining its unspecialized state and, when triggered by the right signals, mature into something entirely different.
How Stem Cells Decide What to Become
Stem cells don’t transform randomly. They live in a specific microenvironment called a “niche,” a dynamic network of neighboring cells, proteins, and physical signals that together control whether a stem cell stays dormant, copies itself, or starts specializing. The niche includes direct contact with surrounding cells, chemical signals like growth factors, and even physical forces like stiffness of the surrounding tissue and oxygen levels.
Think of it like a conversation. The niche sends instructions through molecules that attach to the stem cell’s surface, triggering internal pathways that push the cell toward a particular fate. Some signals tell it to stay put and remain a stem cell. Others tell it to start differentiating into, say, a red blood cell or a neuron. This careful balance is what keeps your tissues healthy over a lifetime, replacing cells lost to normal wear, injury, or disease.
Not All Stem Cells Are Equal
Stem cells vary dramatically in how many cell types they can produce. Scientists categorize them by this “potency.”
- Totipotent: Can produce every cell type in the body plus the placenta. The only undisputed totipotent cell is the zygote, the single cell formed when sperm meets egg.
- Pluripotent: Can become any cell type in the adult body (muscle, brain, liver, blood) but cannot form the placenta or other support tissues needed during pregnancy.
- Multipotent: Can produce several cell types, but only within a single lineage. Blood-forming stem cells in your bone marrow, for example, can generate red blood cells, white blood cells, and platelets, but they won’t produce brain or liver cells.
This hierarchy matters because it determines what each type of stem cell can realistically do in medicine. A pluripotent cell has far more therapeutic flexibility than a multipotent one, but it’s also harder to control.
Embryonic Stem Cells
Embryonic stem cells are pluripotent cells harvested from the inner cell mass of a blastocyst, a hollow ball of about 100 cells that forms roughly five days after fertilization. The inner cell mass is the cluster that would eventually develop into the entire embryo, which is why these cells can produce virtually every tissue type in the human body.
First isolated from mouse embryos in 1981, embryonic stem cells attracted enormous scientific interest because of their potential to generate any cell or tissue “on demand” in a lab. That flexibility makes them powerful tools for studying development and disease. However, their use raises ethical questions because extracting them destroys the embryo. Under current NIH guidelines, federally funded research can only use embryonic stem cells derived from embryos originally created through IVF for reproductive purposes, no longer needed by the donors, and voluntarily donated with written informed consent. Federal law still prohibits NIH funding for the actual process of deriving new stem cell lines from embryos.
Adult Stem Cells
Your body contains stem cells right now, tucked into specific locations across your organs and tissues. These adult (or somatic) stem cells act as a built-in repair system, generating replacements for cells lost through everyday turnover, injury, or disease. They’ve been identified in bone marrow, fat tissue, the lining of the gut, skin, the brain, and many other organs.
Unlike embryonic stem cells, adult stem cells are typically multipotent. A blood-forming stem cell in your bone marrow produces the full range of blood cells but won’t spontaneously become a heart cell. This narrower range makes them less versatile in theory, but it also makes them easier to work with for specific applications. Bone marrow transplants, which have been performed for decades, are essentially adult stem cell therapy: doctors transplant blood-forming stem cells to rebuild a patient’s blood and immune system after chemotherapy or radiation.
Induced Pluripotent Stem Cells
One of the biggest breakthroughs in stem cell science was learning how to rewind an ordinary adult cell back to a pluripotent state. Scientists introduce a specific set of proteins (often called reprogramming factors) into a mature cell like a skin cell. These factors gradually silence the genes that made it a skin cell and reactivate the genes associated with pluripotency.
The process isn’t instant. Early in reprogramming, the cell’s DNA is tightly packed and resistant to change, requiring the reprogramming factors to force open regions of the genome that had been shut down. The silencing of the original cell identity happens first; activation of pluripotency genes comes later. The end result is a cell that behaves much like an embryonic stem cell, able to become nearly any cell type, but created without an embryo. This sidesteps many of the ethical concerns around embryonic stem cell research while opening the door to patient-specific therapies, since the reprogrammed cells carry the patient’s own DNA.
Current Medical Uses
Despite the excitement surrounding stem cells, approved treatments remain limited. The only stem cell therapy routinely reviewed and approved by the FDA is blood stem cell transplantation, used to treat cancers and disorders affecting the blood and immune system. This includes leukemia, lymphoma, sickle cell disease, and certain immune deficiencies. The transplanted stem cells can come from bone marrow, circulating blood, or umbilical cord blood.
Cord blood banking has become a practical decision for expectant parents. Cord blood collected at birth contains blood-forming stem cells effective against roughly 80 diseases. Public cord blood banks accept donations at no cost (if your hospital participates), and the stored units are available to anyone who matches. Private banking, where the cord blood is reserved for your family, typically costs several thousand dollars upfront plus several hundred dollars per year in storage fees. The blood is cryogenically frozen and kept until needed.
What’s Being Tested in Clinical Trials
Beyond blood disorders, researchers are actively testing stem cell therapies for conditions that currently have limited treatment options. One area of significant activity involves a type of stem cell found in bone marrow and fat tissue that can influence the immune system and promote tissue repair. These cells are being studied in clinical trials for multiple sclerosis, where early results show signs of neuroprotection, reduced brain lesion activity on MRI, and modest improvements in disability scores. Short-term safety profiles have been encouraging, though long-term effectiveness and the best methods of delivery are still being worked out across dozens of trials.
Similar trials are underway for heart disease, type 1 diabetes, spinal cord injuries, and neurodegenerative conditions like Parkinson’s disease. The gap between “promising in a trial” and “approved treatment” is significant, often spanning years of additional testing. Clinics that advertise unproven stem cell treatments for conditions like joint pain, anti-aging, or neurological diseases fall outside the scope of FDA-approved therapy, and the risks of unregulated procedures include infection, tumor formation, and wasted money.